Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-β from its activation

Atherosclerosis

Volumn 183, Issue 1, 2005, Pages 85-93

  Sakamoto, Yu Ichiro ^a   Miyazaki, Akira ^b   Tamagawa, Harumi ^a   Wang, Guo Ping ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Inflammation; Oxidized low density lipoprotein; Thrombospondin 1; Transforming growth factor

Indexed keywords

COPPER SULFATE; IODINE 125; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY; SEPHAROSE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL FREE SYSTEM; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; GEL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INCUBATION TIME; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LIPID INTERACTION; REGULATORY MECHANISM;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; CELL-FREE SYSTEM; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CULTURE MEDIA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALE; MICE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 26244453294     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.02.032     Document Type: Article

References (36)

1. J.J. Letterio, and A.B. Roberts Regulation of immune responses by TGF-beta Annu Rev Immunol. 16 1998 137 161
2. K. Miyazono, U. Hellman, and C. Wernstedt Latent high molecular weight complex of transforming growth factor-beta 1. Purification from human platelets and structural characterization J Biol Chem 263 1988 6407 6415
3. R.M. Lyons, L.E. Gentry, and A.F. Purchio Mechanism of activation of latent recombinant transforming growth factor-beta 1 by plasmin J Cell Biol 110 1990 1361 1367
4. R.M. Lyons, J. Keski-Oja, and H.L. Moses Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium J Cell Biol 106 1988 1659 1665
5. M. Abe, N. Oda, and Y. Sato Cell-associated activation of latent transforming growth factor-beta by calpain J Cell Physiol 174 1998 186 193
6. U. Persson, S. Souchelnytskyi, and P. Franzen Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor J Biol Chem 272 1997 21187 21194
7. A. Nakao, T. Imamura, and S. Souchelnytskyi TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 EMBO J 16 1997 5353 5362
8. S. Schultz-Cherry, and J.E. Murphy-Ullrich Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism J Cell Biol 122 1993 923 932
9. S.E. Crawford, V. Stellmach, and J.E. Murphy-Ullrich Thrombospondin-1 is a major activator of TGF-beta1 in vivo Cell 93 1998 1159 1170
10. A.B. Kulkarni, C.G. Huh, and D. Becker Transforming growth factor-beta 1 null mutation in mice causes excessive inflammatory response and early death Proc Natl Acad Sci USA 90 1993 770 774
11. A.G. Geiser, J.J. Letterio, and A.B. Kulkarni Transforming growth factor-beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype Proc Natl Acad Sci USA 90 1993 9944 9948
12. D. Steinberg, S. Parthasarathy, and T.E. Carew Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
13. S. Yla-Herttuala, W. Palinski, and M.E. Rosenfeld Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095
14. M. Kohno, K. Yokokawa, and K. Yasunari Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells Circ Res 81 1997 585 590
15. T. Aoyama, H. Fujiwara, and T. Masaki Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells J Mol Cell Cardiol 31 1999 2101 2114
16. S. Nozaki, H. Kashiwagi, and S. Yamashita Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects J Clin Invest 96 1995 1859 1865
17. Z. Mallat, and A. Tedgui The role of transforming growth factor-beta in atherosclerosis: novel insights and future perspectives Curr Opin Lipidol 13 2002 523 529
18. N. Ohgami, R. Nagai, and M. Ikemoto CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products J Biol Chem 276 2001 3195 3202
19. A. Miyazaki, M. Sakai, and Y. Suginohara Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein J Biol Chem 269 1994 5259 5264
20. K. Takata, S. Horiuchi, and Y. Morino Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation Biochim Biophys Acta 984 1989 273 280
21. A.S. McFarlane Efficient trace-labelling of proteins with iodine Nature 182 1958 53
22. H. Yamashita, P. ten Dijke, and D. Huylebroeck Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects J Cell Biol 130 1995 217 226
23. S. Parthasarathy, N. Santanam, and S. Ramachandran Oxidants and antioxidants in atherogenesis. An appraisal J Lipid Res 40 1999 2143 2157
24. S.M. Ribeiro, M. Poczatek, and S. Schultz-Cherry The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta J Biol Chem 274 1999 13586 13593
25. S. Schultz-Cherry, J. Lawler, and J.E. Murphy-Ullrich The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta J Biol Chem 269 1994 26783 26788
26. H. Chen, M.E. Herndon, and J. Lawler The cell biology of thrombospondin-1 Matrix Biol 19 2000 597 614
27. M. Febbraio, D.P. Hajjar, and R.L. Silverstein CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism J Clin Invest 108 2001 785 791
28. T. Yehualaeshet, R. O'Connor, and J. Green-Johnson Activation of rat alveolar macrophage-derived latent transforming growth factor-beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36 Am J Pathol 155 1999 841 851
29. H. Oka, K. Kugiyama, and H. Doi Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway Arterioscler Thromb Vasc Biol 20 2000 244 250
30. K. Kugiyama, T. Sakamoto, and I. Misumi Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells Circ Res 73 1993 335 343
31. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor-beta in human disease N Engl J Med 342 2000 1350 1358
32. M. Erren, H. Reinecke, and R. Junker Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries Arterioscler Thromb Vasc Biol 19 1999 2355 2363
33. Z. Mallat, A. Gojova, and C. Marchiol-Fournigault Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice Circ Res 89 2001 930 934
34. E. Lutgens, M. Gijbels, and M. Smook Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression Arterioscler Thromb Vasc Biol 22 2002 975 982
35. G. Draude, and R.L. Lorenz TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages Am J Physiol Heart Circ Physiol 278 2000 H1042 H1048
36. C.A. Argmann, Van Den, and C.H. Diepstraten Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants Arterioscler Thromb Vasc Biol 21 2001 2011 2018